phase 3 TROPION-Lung01 trial

Jun 3, 2024 10:53 pm

Insight

Paul Healy: AstraZeneca and Daiichi Sankyo have announced positive results from datopotamab deruxtecan in certain lung cancer patients

NIH Launches a New Initiative to Create a 21st Century Biosafety Framework

Landmark Merger Launches First Institute Dedicated to Aging and Cancer

Gevorg Tamamyan: A Story Everyone Must Read

Top 10 Oncogrants of the Week: Advancing Breakthroughs in Cancer Care

Solange Peters Honored with the IASLC Paul A. Bunn, Jr. Scientific Award 2025